SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2013 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: Biotech Jim who wrote (24)12/31/2012 3:51:54 PM
From: DewDiligence_on_SI  Read Replies (1) | Respond to of 410
 
We both picked XOMA, but for totally different reasons. I ascribe zero value to the CV program, which is owned by Servier; moreover, I doubt that Servier will report any data on the CV program during 2013, so it’s almost impossible for this program to be a near-term driver for XOMA’s share price.

Still, we’re on the same team, so we should have plenty of stuff to talk about in 2013 :- )


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News